Discovery and validation of Lmj_04_BRCT domain, a novel therapeutic target: identification of candidate drugs for leishmaniasis

J Peña-Guerrero, C Fernández-Rubio… - International Journal of …, 2021 - mdpi.com
Since many of the currently available antileishmanial treatments exhibit toxicity, low
effectiveness, and resistance, search and validation of new therapeutic targets allowing the …

Nanotechnology enabled the enhancement of antitrypanosomal activity of piperine against Trypanosoma evansi

R Rani, S Kumar, N Dilbaghi, R Kumar - Experimental Parasitology, 2020 - Elsevier
Nanoencapsulation is the promising approach to enhance the therapeutic potential of a
drug. In the present investigation, piperine-loaded nanocapsules (NCs) was prepared and …

Mechanism of Action and Implication of Naphthoquinone as Potent Anti-trypanosomal Drugs

R Rani, K Sethi, S Gupta, RS Varma… - Current Topics in …, 2022 - ingentaconnect.com
Naphthoquinone is a heterocyclic moiety whose natural derivatives are present as bioactive
compounds in many plants and have stimulated a resurgence of interest in the past decades …

[HTML][HTML] Gum-based nanocapsules comprising naphthoquinones enhance the apoptotic and trypanocidal activity against Trypanosoma evansi

R Rani, B Narsiman, RS Varma, R Kumar - European Journal of …, 2022 - Elsevier
Nanoencapsulation is a promising approach to enhance the therapeutic potential of a drug.
Herein, three selected naphthoquinone (NTQ) derivatives, based on the IC 50 value against …

In vitro anti-trypanosomal effect of ivermectin on Trypanosoma evansi by targeting multiple metabolic pathways

S Gupta, S Vohra, K Sethi, S Gupta, BC Bera… - Tropical animal health …, 2022 - Springer
High cytotoxicity and increasing resistance reports of existing chemotherapeutic agents
against T. evansi have raised the demand for novel, potent, and high therapeutic index …

Naphthoquinone derivatives exhibit apoptosis-like effect and anti-trypanosomal activity against Trypanosoma evansi

R Rani, B Narasimhan, RS Varma, R Kumar - Veterinary Parasitology, 2021 - Elsevier
Trypanosoma evansi is an extracellular flagellate blood protozoan parasite and an
etiological agent of animal trypanosomosis. Presently, only a few drugs are registered and …

In vitro and in vivo evaluation of kinase and protease inhibitors against Trypanosoma evansi

WD Bhutia, S Gupta, R Rani, K Batra, K Sethi… - Veterinary research …, 2023 - Springer
Trypanosoma evansi is a causative agent of chronic wasting and fatal disease of livestock
and wild animals known as surra. In this study, repurposing approach based on drug target …

Gene expression study to elucidate the anti-trypanosomal activity of quinapyramine methyl sulphate (QPS)

S Gupta, S Vohra, K Sethi, S Gupta, S Kumar… - Parasitology …, 2022 - Elsevier
The kinetoplastid protozoan parasite, Trypanosoma evansi causes a fatal disease condition
known as Surra in equines throughout the globe. Disease condition being acute in nature …

Intracellular ROS production and apoptotic effect of quinoline and isoquinoline alkaloids on the growth of Trypanosoma evansi

R Rani, K Sethi, S Gupta, N Virmani, S Kumar, R Kumar - Acta Tropica, 2023 - Elsevier
Trypanosoma evansi, a hemoflagellate poses huge economic threat to the livestock industry
of several countries of Asia, Africa, South America and Europe continents of the world …

Study of mRNA expression levels in steady state Trypanosoma evansi for plausible selection of housekeeping and drug target genes

S Gupta, S Vohra, R Kumar - 2023 - indianjournals.com
Surra is a dreadful infectious protozoan disease affecting many animal hosts. Emerging drug
resistance, a limited number of drugs, and their high cytotoxicity have motivated researchers …